Enhancement of colony forming ability in the lung by transfer of the v-fos oncogene into a ras-transformed rat 3Y1 cell line  by Nakamatsu, Kohji et al.
Volume 257, number 2, 422-426 FEB 07805 November 1989 
Enhancement of colony forming ability in the lung by transfer of the 
v-fos oncogene into a ras-transformed rat 3Y 1 cell line 
Kohji Nakamatsu, Shun’ichiro Taniguchi, Genki Kimura* and Tsuneo Baba 
deportment of ExperimentuI Cell Research and ~~epartment of‘ Virology, Medical Znstitute of ~ioregu~ation, Kyushu university 69, 
3-I-1, Maidashi, Higashi-ku, Fukuoka 812, Japan 
Received 22 July 1989 
Transfer of the v-fos oncogene into a rat 3Y 1 cell line transformed by v-H-ras, which is tumorigenic but non-metastatic, enhanced lung metastasis, 
depending on the amount of fos-related transcripts..“› Enhancement of the metastatic potential was associated with increases in tumor growth rate 
i.m. of inoculated cells but not the rate of in vitro cell growth, irrespective of the addition of tissue (e.g. lung) extract o the regular medium. These 
results uggest hat the v-fos oncogene increased the malignancy by altering biological factors of the recipient cells responsible for cell growth and/or 
survival rate in vivo. 
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1. INTRODUCTION 
Amplification, structural change or the expression of 
several oncogenes eems to be related to the metastatic 
potential of certain tumor cells [l-6]. Transfer of the 
active c-H-ras modifies the metastatic potential [7-91. 
It was also noted that expression of the fos oncogene 
which encodes nuclear protein [IO-121, was increased 
in highly metastatic ell lines of rat spontaneous mam- 
mary carcinoma 1131. We reported that transfer of the 
v-fos gene into a rat cell line transformed by v-src 
enhanced the metastatic potential to the lung [ 14,151. 
We have now obtained evidence that transfer of the v- 
fos oncogene into a rat cell line transformed by v-H-ras 
also enhanced metastasis in the lung and the growth 
rate in vivo, with no change in the potential for growth 
in vitro. 
2. MATERIALS AND METHODS 
2.1. Cells and DNA transfe~tion 
A transformed rat fibroblast cell line, HR-3Yl-3, was established 
by transfection of the cloned v-Ha-ras gene, Ha-MuSV L clone [16], 
into a normal rat fibroblast cell line, 3Y 1-B clone 1-6 [ 171. The cloned 
v-fos gene, pFBJ-2 (lOpg/dish) [18], was co-transfected with 
pSV2-neo (1 pg/dish) [19] into HR-3Yl-3 (l-3 x 10’ celIs/dish) by 
calcium phosphate precipitation, as described [14,15]. Independent 
colonies resistant o 4OOpg/ml Geneticin (G418, Gibco), one colony 
from one dish, were isolated and designated as fos-HR-3Y1-301 to 
309. Fos-HR-3Y1-308a nd 308b were isolated from one dish. As the 
control, pBR322 and pSV2-neo were cotransfected into HR-3Yl-3 
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cells. Mixed populations of the combined colonies (about 200 col- 
onies) resistant o G418 were designated as fos-HR-3Y I-300 or neo- 
HR-3Y I-300, respectively. All the eel1 lines were cultured in Dulbec- 
co’s modified Eagle’s medium (DMEM) supplemented with 10% 
fetal bovine serum. 
2.2. Southern blot analysis and Norther blot analysis 
Southern blot analysis was performed, as described [14,15]. The 
blot was autoradiographed using Kodak XAR-5 film at -80°C for 
48 h. Northern blot analysis was performed, as described [14,15]. 
RNA prepared by the guanidinium/cesium method was eiec- 
trophoresed through 1.2% agarose0.8 M formaldehyde gel and 
blotted to nitrocellulose. 
2.3. Expmmental lung metastasis in rats 
To assess the extent of experimental metastasis, 1 x lo6 of viable 
cells were injected into the tail vein of syngeneic female F344 rats and 
these rats were killed when moribund (20-35 days after inoculation). 
The lungs were removed, fixed with Bouin’s solution and examined 
for the presence of metastases. Several metastatic lung nodules were 
explanted in vitro and cultured in DMEM medium containing 10% 
FBS and G418 (4OOpg/ml). These cell lines were designated by ad- 
ding -FI to the parent cell lines. 
2.4. Tumor development 
The size of the tumor formed by the i.m. inoculated cells (1 x 106) 
into the thigh of F344 rats was monitored until the rats died, 
2.5. In vitro growth rate 
Cells were seeded at 1 x IO5 in a 0 60-mm dish and cultured in 
DMEM with 10% FBS, then were harvested with trypsin and counted 
every 24 h for 5 days. 
2.6. Effect of lung exfract on in vitro growth 
Preparation of lung extract and assay of the growth stimulating ac- 
tivity were done according to Yamori et al. [20]. Briefly, cells were 
suspended in DMEM containing 1% fetal bovine serum and plated 
on a @ CO-mm dish at a concentration of 5 x lo4 cells. After incuba- 
tion for 24 h at 37”C, the attached cells were counted (time 0 count) 
and fed DMEM containing 10 mM Hepes buffer and 100 pg of pro- 
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tein of the lung extract per ml prepared from fresh lungs of normal 
F344 rats. Growth index was defined by dividing the cell counts at 
each time point by time 0 counts. 
3. RESULTS 
3.1. Southern blot analysis 
Fig.1 shows Southern blot analysis of the genomic 
DNA from the transfectants, digested with SmaI. All 
the cell lines had a common 13 kb DNA fragment 
which contained the cellular fos (c-fos) gene. All of the 
v-fos transfected cell lines had an additional 4.0 kb 
fragment containing the entire coding region of the v- 
fos originated from the transfected pFBJ-2 DNA. 
In some transfectants, various additional hybridizing 
fragments were evident, showing random integration of 
the v-fos DNA upon transfection. Second generations 
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Fig.1. Southern blot analysis of the presence of the v-fos DNA 
sequences in SmaI-digested DNA (20 pg) from pFBJ-2-transfected 
HR-3Yl-3 cells. Hybridization was performed with the “P-labeled 
fos-specific PstI DNA fragment (1 kb) of p-fos-1 [18]. Lanes O-9, 
fos-HR-3Y!-300 to fos-HR-3Y I-309; lane neo, neo-HR-3Y l-300; 
Iane HR, HR-3Yl-3; lane 3Y1, 3Yl-B clone l-6; lanes 7Fl-1 to 
8bFI-2, fos-HR-3Yl-307Fl-1 to fos-HR-3Yl-308bFl-2. Arrows 
px F 
Fig.2. Northern blot analysis showing the fos-related transcript in v- 
fos-transferred HR-3Yl-3 cells. RNA on the filters was hybridized 
with the same probe used for Southern blot analysis and after that 
with an actin probe showing 2.1 kb actin 1211 as an internal 
quantitative control for the amounts of RNA on the filters. The 
relative level of fos-related transcripts was calculated by dividing the 
density of fos bands by that of actin bands on the autora~ograph~ 
X-ray films. The values are listed in table 1. The density was 
show 13 kb c-fos and 4.0 kb v-fos DNA fragments. measured using a Video Densitometer (Bio-Rad). 
of fos-transferred cells established from lung colonies 
(fig. I, below) retained the exogenous fos DNA. 
3.2. ~orihern blot analysis 
Fig.2 shows Northern blot analysis of the RNA 
hybridized with the fos-specific probe. To compare the 
amount of fos-related transcripts, the filters were wash- 
ed and rehybridized with an actin probe [21] which 
detects a 2.1-kb actin-specific transcript, confirmed in 
advance not to differ in expression among the cell lines. 
Two sizes of the fos-related transcripts (3.4 kb and 
5.6 kb) were seen in some of the transfectants (fos- 
HR-3Y l-301, 307, 308a, 308b). Other fos-transfected 
cell lines and control cell lines (neo-HR-3Yl-300, 
HR3Y 1-3, 3Y l-l-6) expressed little fos-related 
transcripts. Second generations, such as fos- 
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Table 1 
Presence and expression of the v-fos gene, and experimental lung metastasis of fos-transfected HR-3Y l-3 
cells 
Cell line Experimenta 4.0 kb of Relative level of Lung metastasis 
fos DNAb fos expression’ 
(RNA) No. of lung nodulesd Incidence’ 
fos-HR-3Y l-307 A + 3.5 153.2 * 54.8 6/6 
fos-HR-3Y 1-308b A + 6.6 182.7 + 11.1 7/7 
fos-HR-3Y l-309 A + 0 0 O/6 
neo-HR-3Yl-300 A _ 0 0 O/6 
HR-3Y l-3 A _ 0 0 O/6 
fos-HR-3Y l-301 B + 8.8 269.0 + 30.5 6/6 
fos-HR-3Yl-302 B + 0 0.5 + 0.3 l/6 
fos-HR-3Y l-305 B + 0 4.4 t 1.9 515 
fos-HR-3Y 1-308a B + 10.3 214.9 + 45.7 6/6 
fos-HR-3Y l-304 C + 0 0.8 + 0.2 l/6 
fos-HR-3Y l-306 C + 0 0.2 + 0.2 l/6 
fos-HR-3Yl-307Fl-1 C + 21.9 334.2 + 40.8 6/6 
fos-HR-3Yl-307Fl-2 C + 16.0 136.2 f 10.4 5/6 
fos-HR-3Yl-308bFl-1 D + 6.4 361.0 * 30.3 6/6 
fos-HR-3Yl-308bFl-2 D + 6.4 233.4 t 40.3 6/6 
a Rats were examined 33 days in experiment A, 35 days in experiment B, 22 days in experiment C, and 
20 days in experiment D after i.v. inoculation 
b All the cell lines have a common 13 kb of c-fos DNA 
’ The level was determined by dividing the density of fos transcripts by that of the actin band 
d Mean k SD 
’ Numbers of rats bearing lung metastasis/total rats 
HR-3Yl-307Fl-1 and 308bFl-2, also expressed fos- 
related transcripts. 
3.3. Experimental ung metastasis 
As shown in table 1, no colony was seen in the lung 
of the rats inoculated with HR-3Yl-3 or neo- 
HR-3Yl-300, in which the fos-related transcript was 
not evident. Lung colonies were few in fos-transferred 
cell lines not expressing detectable fos transcripts. 
These cell lines produced no pulmonary metastases, 
either macroscopically or microscopically, even 60 days 
after i.v. inoculation. On the other hand, the cell lines 
(fos-HR-3Y l-307, 308b, 301, 308a) expressing fos- 
related transcripts, produced a number of lung col- 
onies. The cell lines of second generation (fos- 
HR-3Y l-307Fl-1 through 308bFl-2) also expressed a 
large amount of fos-related transcripts and the 
metastatic potential to the lung was high. 
3.4. Tumor development 
Growth rate of the tumors produced by cell lines with 
relatively high levels of fos expression (fos-HR-3Yl-307 
in fig.3A,B and 308a, 307Fl-1 in fig.3B), was larger 
than that of cell lines with little expression of fos- 
related transcript (fos-HR-3Y l-309 in fig.3A and fos- 
HR-3Y l-306 in fig.3B), or of the control cell line (neo- 
HR-3Yl-300 in fig.3A). 
3.5. In vitro growth 
As shown in fig.4A, in vitro growth rate and satura- 
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tion density of the cells were much the same among the 
cell lines examined and did not correlate with the 
relative level of fos expression. 
Fig.4B shows the effect of lung extract on in vitro cell 
growth. The growth rate of the highly metastatic ell 
line, fos-HR-3Yl-308a did not surpass that of low 
metastatic cell lines, fos-HR-3Yl-309. or neo-HR- 
3Yl-300. 
A 
Fig.3. Change in size of tumors formed by inoculation of v-fos- 
transferred HR-3Yl-3 cells. Two experiments are shown (A,B). 
Tumor size was measured using a caliper after i.m. inoculation into 
the thigh of five F344 rats. The growth curve represents the mean of 
tumor volume calculated by ab2/2 (a, long axis; b, short axis). Bars 
show SD. (A) fos-HR-3Yl-307; (0) fos-HR-3Yl-309; (m) neo- 
HR-3Yl-300; (+) fos-HR-3Yl-308a; (v) fos-HR-3Yl-307Fl-1; (0) 
fos-HR-3Y I-306. 
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IA lB 
Fig.4. (A) In vitro growth rate of the v-fos and/or neo-transferred 
HR-3Yl-3 cells. 1 x 10’ cells were seeded in triplicate on 60 mm 
culture dishes and cultured in DMEM containing 10% FBS. Numbers 
of cells were counted every 24 h for 5 days. (A) fos-HR-3Y l-307; (e) 
fos-HRJY 1-308a; (e) fos-HR-3Y l-309; (0) neo-HR3Y l-300. (B) 
Effect of rat lung extract on the growth of fos-transferred cells. 
Growth medium was replaced at time 0 with serum-free DMEM 
containing 1OOpg protein of lung extract per ml. Growth index was 
determined as described in section 2. The symbols are the same as 
those in (A). 
4. DISCUSSION 
Transfer of the v-fos oncogene into a ras- 
transformed rat cell line (HR-3Y l-3) enhanced colony- 
forming ability in the lung (table i), depending on the 
amount of fos-related transcripts. Although other in- 
vestigators uggested that transfer of the active c-H-ras 
modified the metastatic potential [7-91, our cell line 
transformed by v-H-ras (HR-3Y l-3) produced no 
metastatic nodules in the lung. Furthermore, no 
remarkable alteration in the expression of v- or c-H-ras 
was seen among the fos-transferred cell lines and the 
control cell line (data not shown). 
Highly metastatic transfectants with a high level of 
fos expression showed a higher growth rate after i.m. 
inoculation than did cell lines with little fos expression 
(fig.3), but not correlating with the growth rate in vitro. 
Difference in metastatic potential of certain cell lines 
has been explained by response of the cells to tissue- 
originated growth factors. Yamori et al. [20] reported 
that the addition of lung extract to culture medium 
selectively stimulated the growth of a highly metastatic 
clone of mouse colon tumor cells. This was, however, 
not the case in our experiments, as growth rate of the 
highly metastatic cell line (fos-HR-3Yl-308a) did not 
surpass that of the low metastatic cell line (fos- 
HR-3Y l-309) or the control cell line (neo-HR-3Y l-300) 
when Iung extract was added to the culture medium 
(fig.4B). Similar results were obtained by adding mus- 
cle extract, prepared from thighs of syngeneic F344 rats 
(unpublished data). In preliminary experiments, fos- 
transferred highly metastatic cell lines tended to be 
more resistant o splenic effecters than did the controls. 
Thus, increases in lung metastasis and growth rate i.m. 
of the H-ras-transformed 3Yl cell line by fos transfer 
may be attributed to the augmentation of cellular 
resistance to host defence systems. Alternatively, fos 
transfer might have promoted expression of 
angiogenesis factors, advantageous for cellular growth 
in vivo. Determination of biological factors responsible 
for fos-transferred highly metastatic ell lines are under 
way. 
Fos protein is a nuclear compound and binds with a 
high affinity to DNA cellulose, in vitro [lO,ll]. We 
observed that the nuclei of fos-HR-3Yl-308a, express- 
ing a high level of fos transcripts, were immunostained 
with antibodies specific for the v-fos protein, while 
those of neo-HR-3Yl-300 did not (data not shown). 
Recent evidence suggests that the nucleoprotein com- 
plex containing the fos product binds to the AP-1 
recognition site of the fat specific element 2 (FSE 2) 
located upstream of the adipocyte P2 (aP2) gene 
[ 12,221. AP-1, also a nuclear oncoprotein encoded by 
c-jun [23] and identical to the fos-associated protein 
p39 [24], is considered to form DNA-binding protein 
complexes with fos protein that functions as a 
transcriptional regulator [22]. How fos-associating pro- 
teins such as AP-1 are related to the function of the v- 
fos in our cell lines remains to be clarified. 
We reported [ 14,151 that the transfer of the v-fos on- 
cogene into a rat cell line transformed by v-src 
(SR-3Yl-2) increased metastasis to the lungs. These cell 
lines showed both experimental and spontaneous 
metastatic potentials, while fos-transferred HR-3Yl-3 
cell lines produced few spontaneous metastases in the 
lung. Furthermore, the metastatic potential of the fos- 
transferred SR-3Yl-2 cell lines correlated with the 
degree of invasiveness. Therefore, genes responsible for 
metastatic potential, the expression of which is affected 
by the v-fos products, appear to depend on the type of 
recipient cells. Identification of genes regulated by the 
v-fos product in our cell systems, is the subject of ongo- 
ing study. 
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